Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 9301 AL 9315

Early detection and management of hearing loss to reduce dementia risk in older adults with mild cognitive impairment: findings from the treating auditory impairment and cognition trial (TACT)

Yu RC, Pavlou M, Schilder AGM, Bamiou DE, Lewis G, Lin FR, Livingston G, Proctor D, Omar R, Costafreda SG.

Age Ageing. 2025 Jan 6;54(1):afaf004. doi: 10.1093/ageing/afaf004.

The effect of tablet-based multimodal training on cognitive functioning in Alzheimer's disease: A randomized controlled trial

Zuschnegg J, Ropele S, Opriessnig P, Schmidt R, Russegger S, Fellner M, Leitner M, Spat S, Garcia ML, Strobl B, Ploder K, Pszeida M, Hofmarcher-Holzhacker MM, Stoegerer-Oberschmid E, Guttmann-Lattmanig A, Paletta L, Schüssler S, Koini M.

PLoS One. 2025 Aug 13;20(8):e0329931. doi: 10.1371/journal.pone.0329931. eCollection 2025.

Effect of Initiation and Continuous Adherence to ARBs Versus ACEIs on Risk of Adjudicated Mild Cognitive Impairment or Dementia

Derington CG, Berchie RO, Scharfstein DO, Andrews RM, Greene TH, Xu Y, King JB, Supiano MA, Sonnen JA, Williamson J, Pajewski NM, Pruzin JJ, Cohen JB, Bress AP.

J Gerontol A Biol Sci Med Sci. 2025 Jun 10;80(7):glaf028. doi: 10.1093/gerona/glaf028.

Delirium: a modifiable risk factor for dementia

van Munster BC, Strijkert F, Trzpis M, Slooter AJC, van den Boogaard M, Ottens TH; DELIER-NL: the Dutch Interdisciplinary Delirium Network.

Eur Geriatr Med. 2026 Apr;17(2):549-552. doi: 10.1007/s41999-025-01360-3. Epub 2025 Nov 21.

Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment: Metformin in Alzheimer Dementia Prevention (MAP)

Luchsinger JA, Devanand D, Goldberg TE, Cammack S, Hernández-Santiago G, Oishi K, Jagust W, Baker S, Landau S, Yenokyan G, Betz J, Mayers S, Eyzaguirre LM, Hanley D; MAP Study Group.

Alzheimer Dis Assoc Disord. 2025 Apr-Jun 01;39(2):123-133. doi: 10.1097/WAD.0000000000000677. Epub 2025 May 28.

Association between social networking and dementia: A systematic review of observational studies

Arshad F, Boopalan D, Arora S, Rosen HJ, Alladi S.

Neuroscience. 2025 Jun 7;576:138-148. doi: 10.1016/j.neuroscience.2025.04.019. Epub 2025 Apr 19.

Sativex (nabiximols) for the treatment of Agitation & Aggression in Alzheimer's dementia in UK nursing homes: a randomised, double-blind, placebo-controlled feasibility trial

Albertyn CP, Guu TW, Chu P, Creese B, Young A, Velayudhan L, Bhattacharyya S, Jafari H, Kaur S, Kandangwa P, Carter B, Aarsland D.

Age Ageing. 2025 May 31;54(6):afaf149. doi: 10.1093/ageing/afaf149.

Functional Imaging in Alzheimer's Disease: A Systematic Review and Meta-Analysis of ASL-MRI and FDG-PET

Radmard M, Gad M, Sheikhy A, Dagher R, Yedavalli V, Luna LP.

J Neuroimaging. 2025 Sep-Oct;35(5):e70080. doi: 10.1111/jon.70080.

Brexpiprazole for agitation in clinically relevant patient subgroups: a post hoc analysis of efficacy and safety in patients with agitation associated with dementia due to Alzheimer's disease

Stroud J, Cummings JL, Chumki SR, Such P, Wang D, Palma AM, Zhang Z, Brubaker M, Grossberg GT.

Curr Med Res Opin. 2025 Aug;41(8):1523-1534. doi: 10.1080/03007995.2025.2552278. Epub 2025 Sep 5.

Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer's Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled, 78-Week APOLLOE4 Trial

Abushakra S, Power A, Watson D, Porsteinsson A, Sabbagh M, MacSweeney E, Cohen S, Boada Rovira M, Doraiswamy PM, Liang E, Flint S, Kesslak JP, McLaine R, Albayrak A, Schaefer J, Yu J, Tolar L, Dickson S, Hey JA, Tolar M.

Drugs. 2025 Nov;85(11):1455-1472. doi: 10.1007/s40265-025-02250-5. Epub 2025 Sep 28.

Multidomain interventions for prevention of dementia: Achievements, challenges and future perspectives

Sakurai T, Sugimoto T, Arai H.

Geriatr Gerontol Int. 2025 Aug;25(8):1015-1034. doi: 10.1111/ggi.70088. Epub 2025 Jun 17.

Pulling Back the Curtain on Hospital Dementia Detection: Validation of the Informant-Based Clinical Dementia Rating

Aliberti MJR, Avelino-Silva TJ, Covinsky KE, Bertola L, Magaldi RM, Boyd CM, Carpenter CR, Yassuda MS, Suemoto CK; CHANGE Study Group.

J Am Geriatr Soc. 2025 Aug;73(8):2524-2530. doi: 10.1111/jgs.19494. Epub 2025 May 2.

Objective Criteria for Subtle Cognitive Decline in Aging and Preclinical Alzheimer Disease: A Systematic Review

Thomas KR, Edmonds EC.

Neurology. 2025 May 13;104(9):e213536. doi: 10.1212/WNL.0000000000213536. Epub 2025 Apr 8.

Does pneumonia increase the risk of dementia and cognitive decline? A systematic review and meta-analysis

Yan Z, Zhang M, Yu L, Zhang F.

Ann Med. 2025 Dec;57(1):2517376. doi: 10.1080/07853890.2025.2517376. Epub 2025 Jun 23.

Natural disaster-induced dementia and cognitive decline: A meta-analysis and systematic review

Thompson J, Vasefi M.

Soc Sci Med. 2025 Apr;371:117898. doi: 10.1016/j.socscimed.2025.117898. Epub 2025 Feb 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias